US EditionPuberty blockers will not be routinely offered to children at new gender clinics
- The UK's National Health Service has prohibited the use of puberty blockers to alter the biology of children for gender transition, except in approved clinical trials.
- Trans identification is recognized as possibly being a transient phase, and the use of puberty blockers and cross-sex hormones for those 16 and older has not yet been approved.
- Other European countries have also become cautious about using puberty blockers and hormones, but the problem remains in the US, where politicians and media are promoting the ideology despite evidence to the contrary.
62 Articles
62 Articles
England’s health service says it won’t give puberty blockers to children at gender clinics - Boston News, Weather, Sports
LONDON (AP) — The publicly funded health service in England has decided it will not routinely offer puberty-blocking drugs to children at gender identity clinics, saying more evidence is needed about the potential benefits and harms. The National Health Service said Friday that “outside of a research setting, puberty-suppressing hormones should not be routinely commissioned for children and adolescents.” People under 18 can still be given pubert…
England's Health Service Will Stop Giving Puberty Blockers to Children at Gender Clinics
The National Health Service said Friday that ‘outside of a research setting, puberty suppressing hormones should not be routinely commissioned for children and adolescents.’
England's health service says it won't give puberty blockers to children at gender clinics
LONDON (AP) — The publicly funded health service in England has decided it will not routinely offer puberty-blocking drugs to children at gender identity clinics, saying more evidence is needed about the potential benefits and harms.
Coverage Details
Bias Distribution
- 45% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
